Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Development of a Gastrointestinal-Myoelectrical-Activity-Based Nomogram Model for Predicting the Risk of Mild Cognitive Impairment

Li B, Ji S, Peng A, Yang N, Zhao X, Feng P, Zhang Y, Chen L.

Biomolecules. 2022 Dec 12;12(12):1861. doi: 10.3390/biom12121861.

[A case of non-fluent/agrammatic variant of primary progressive aphasia with logoclonia]

Shimazaki R, Sunami Y, Bando M, Harada A, Takahashi K.

Rinsho Shinkeigaku. 2023 Jan 28;63(1):7-14. doi: 10.5692/clinicalneurol.cn-001628. Epub 2022 Dec 24.

Amyloid-β PET in Alzheimer's disease: A systematic review and Bayesian meta-analysis

Ruan D, Sun L.

Brain Behav. 2023 Jan;13(1):e2850. doi: 10.1002/brb3.2850. Epub 2022 Dec 27.

Commentary on Comparison of Machine Learning-based Approaches to Predict the Conversion to Alzheimer's Disease from Mild Cognitive Impairment

Rossini PM, Miraglia F, Vecchio F.

Neuroscience. 2023 Mar 15;514:141-142. doi: 10.1016/j.neuroscience.2022.12.018. Epub 2022 Dec 30.

An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer's Disease

Verma RK, Pandey M, Chawla P, Choudhury H, Mayuren J, Bhattamisra SK, Gorain B, Raja MAG, Amjad MW, Obaidur Rahman S.

CNS Neurol Disord Drug Targets. 2022;21(10):901-912. doi: 10.2174/1871527320666210512014505.

A Concise Overview of Biosensing Technologies for the Detection of Alzheimer's Disease Biomarkers

Talebi M, Esmaeeli H, Talebi M, Farkhondeh T, Samarghandian S.

Curr Pharm Biotechnol. 2022;23(5):634-644. doi: 10.2174/2666796702666210709122407.

Lipids as Early and Minimally Invasive Biomarkers for Alzheimer's Disease

Casas-Fernández E, Peña-Bautista C, Baquero M, Cháfer-Pericás C.

Curr Neuropharmacol. 2022;20(8):1613-1631. doi: 10.2174/1570159X19666211102150955.

Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease

Kumari S, Singh A, Singh AK, Yadav Y, Bajpai S, Kumar P, Upadhyay AD, Shekhar S, Dwivedi S, Dey AB, Dey S.

J Alzheimers Dis. 2022;85(1):249-260. doi: 10.3233/JAD-215347.

A Case of Possible Chronic Traumatic Encephalopathy and Alzheimer's Disease in an Ex-Football Player

Fesharaki-Zadeh A.

Neurologist. 2022 Sep 1;27(5):249-252. doi: 10.1097/NRL.0000000000000391.

Sphingomyelins and ceramides: possible biomarkers for dementia?

Loft LMI, Moseholm KF, Pedersen KKW, Jensen MK, Koch M, Cronjé HT.

Curr Opin Lipidol. 2022 Feb 1;33(1):57-67. doi: 10.1097/MOL.0000000000000804.

Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer's disease

Creese B, Ismail Z.

Alzheimers Res Ther. 2022 Jan 5;14(1):2. doi: 10.1186/s13195-021-00949-7.

Exosomes-Potential for Blood-Based Marker in Alzheimer's Disease

Li CC, Hsu WF, Wo AM.

Acta Neurol Taiwan. 2022 Jan 25;31(1):1-6.

Imaging biomarkers for Alzheimer's disease and glaucoma: Current and future practices

Martucci A, Picchi E, Di Giuliano F, Pocobelli G, Mancino R, Toschi N, Russo R, Floris R, Garaci F, Nucci C.

Curr Opin Pharmacol. 2022 Feb;62:137-144. doi: 10.1016/j.coph.2021.12.003. Epub 2022 Jan 4.

Promising protein biomarkers in the early diagnosis of Alzheimer's disease

Sharma L, Sharma A, Kumar D, Asthana MK, Lalhlenmawia H, Kumar A, Bhattacharyya S, Kumar D.

Metab Brain Dis. 2022 Aug;37(6):1727-1744. doi: 10.1007/s11011-021-00847-9. Epub 2022 Jan 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias